Research graph

References

References from ASO Visual Abstract: Prognostic Benefit of Sequential Locoregional Interventions During First-Line Systemic Therapy for Hepatocellular Carcinoma: Insights from Interaction Analysis of Lenvatinib and Atezolizumab/Bevacizumab. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.